ID

20766

Description

Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01517555

Lien

https://clinicaltrials.gov/show/NCT01517555

Mots-clés

Versions (2)
  1. 15/03/2017 15/03/2017 -
  2. 15/03/2017 15/03/2017 -
Téléchargé le

15 mars 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes NCT01517555

Anglais

Eligibility Diabetes NCT01517555

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01517555
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Description

Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
diet-treated subjects with type 2 diabetes with hba1c 7.5-9.5 %
Description

Diet therapy Non-Insulin-Dependent Diabetes Mellitus | Glycosylated hemoglobin A Percentage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012159
UMLS CUI [1,2]
C0011860
UMLS CUI [2,1]
C0019018
UMLS CUI [2,2]
C0439165
subjects with type 2 diabetes in oral anti-diabetic drug (oad) monotherapy treated with metformin or alpha-glucosidase inhibitors with hba1c 7.0-9.5%
Description

Antidiabetics Oral Non-Insulin-Dependent Diabetes Mellitus | Metformin | alpha-Glucosidase Inhibitors | Glycosylated hemoglobin A Percent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0011860
UMLS CUI [2]
C0025598
UMLS CUI [3]
C1299007
UMLS CUI [4,1]
C0019018
UMLS CUI [4,2]
C0439165
body mass index (bmi) 18.5-40 kg/m^2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
subjects should have a stable body weight for at least 3 months prior to screening (as judged by the investigator)
Description

Stable body weight

Type de données

boolean

Alias
UMLS CUI [1]
C0517386
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired liver function
Description

Liver Dysfunction

Type de données

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Description

Renal Insufficiency

Type de données

boolean

Alias
UMLS CUI [1]
C1565489
clinically significant active cardiovascular disease including history of myocardial infarction within the last 6 months and/or heart failure
Description

Cardiovascular Diseases | Myocardial Infarction | Heart failure

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0018801
any clinically significant abnormal ecg (electrocardiogram)
Description

Electrocardiogram abnormal

Type de données

boolean

Alias
UMLS CUI [1]
C0522055
uncontrolled treated/untreated hypertension
Description

Uncontrolled hypertension Treated | Uncontrolled hypertension untreated

Type de données

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C1522326
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0332155
recurrent severe hypoglycaemia as judged by the investigator
Description

Recurrent severe hypoglycemia

Type de données

boolean

Alias
UMLS CUI [1]
C0342316
active hepatitis b and/or active hepatitis c
Description

Hepatitis B | Hepatitis C

Type de données

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
positive human immunodeficiency virus (hiv) antibodies
Description

HIV antibody positive

Type de données

boolean

Alias
UMLS CUI [1]
C0920548
known or suspected allergy to trial product(s) or related products
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Related

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439849
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0750491
UMLS CUI [3,3]
C0013230
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013227
UMLS CUI [4,4]
C0439849
Retour au début de la page

Similar models

Eligibility Diabetes NCT01517555

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01517555
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Diet therapy Non-Insulin-Dependent Diabetes Mellitus | Glycosylated hemoglobin A Percentage
Item
diet-treated subjects with type 2 diabetes with hba1c 7.5-9.5 %
boolean
C0012159 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C0019018 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
Antidiabetics Oral Non-Insulin-Dependent Diabetes Mellitus | Metformin | alpha-Glucosidase Inhibitors | Glycosylated hemoglobin A Percent
Item
subjects with type 2 diabetes in oral anti-diabetic drug (oad) monotherapy treated with metformin or alpha-glucosidase inhibitors with hba1c 7.0-9.5%
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0011860 (UMLS CUI [1,3])
C0025598 (UMLS CUI [2])
C1299007 (UMLS CUI [3])
C0019018 (UMLS CUI [4,1])
C0439165 (UMLS CUI [4,2])
Body mass index
Item
body mass index (bmi) 18.5-40 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Stable body weight
Item
subjects should have a stable body weight for at least 3 months prior to screening (as judged by the investigator)
boolean
C0517386 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Liver Dysfunction
Item
impaired liver function
boolean
C0086565 (UMLS CUI [1])
Renal Insufficiency
Item
impaired renal function
boolean
C1565489 (UMLS CUI [1])
Cardiovascular Diseases | Myocardial Infarction | Heart failure
Item
clinically significant active cardiovascular disease including history of myocardial infarction within the last 6 months and/or heart failure
boolean
C0007222 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0018801 (UMLS CUI [3])
Electrocardiogram abnormal
Item
any clinically significant abnormal ecg (electrocardiogram)
boolean
C0522055 (UMLS CUI [1])
Uncontrolled hypertension Treated | Uncontrolled hypertension untreated
Item
uncontrolled treated/untreated hypertension
boolean
C1868885 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Recurrent severe hypoglycemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0342316 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
active hepatitis b and/or active hepatitis c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
HIV antibody positive
Item
positive human immunodeficiency virus (hiv) antibodies
boolean
C0920548 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Related
Item
known or suspected allergy to trial product(s) or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0750491 (UMLS CUI [3,2])
C0013230 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
C0439849 (UMLS CUI [4,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial